Audrey Haywood, J. Castaneda, K. Proud, M. Restrepo, A. Díaz, D. Maselli
{"title":"The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis","authors":"Audrey Haywood, J. Castaneda, K. Proud, M. Restrepo, A. Díaz, D. Maselli","doi":"10.1183/13993003.congress-2019.pa1394","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1394","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"147 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115380798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Donadieu, Jessica Kabla-Assouline, R. Chiron, S. Héritier, V. Valle, C. Delestrain, M. Kambouchner, H. D. Pointe, R. Epaud
{"title":"Lung involvement in childhood Langerhans cell histiocytosis, A multi-institutional study from the french LCH study group","authors":"J. Donadieu, Jessica Kabla-Assouline, R. Chiron, S. Héritier, V. Valle, C. Delestrain, M. Kambouchner, H. D. Pointe, R. Epaud","doi":"10.1183/13993003.congress-2019.oa5157","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.oa5157","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"108 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124149278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Ostrovskyy, K. Ostrovska, K. Shvets, I. Savelikhina, O. Varunkiv, N. Korzh
{"title":"Epidemiology of sarcoidosis in Western Ukraine","authors":"M. Ostrovskyy, K. Ostrovska, K. Shvets, I. Savelikhina, O. Varunkiv, N. Korzh","doi":"10.1183/13993003.congress-2019.pa1949","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1949","url":null,"abstract":"Background: The research work is related to epidemiology of sarcoidosis in Ivano-Frankivsk region (West Ukraine). Many scientists connect the etiology of sarcoidosis with geografical and climatic factors. In Ukraine it is considered that the lowest (1.1 case per 100 thousand people) incidence were noticed in Crimea (South Ukraine), while the highest rates were marked in North Ukraine (incidence – 2.62 cases per 100 thousand people). Aim: to study of prevalence and of sarcoidosis in Western Ukraine. Material and Methods: Statistical data were obtained by processing hospital records of 470 patients from Ivano-Frankivsk regional phthysiopulmonary centre in 2011-2015. Results: The incidence of sarcoidosis in Ivano-Frankivsk region was 1.08 times higher than the maximal rate in Ukraine and made up 2.83 cases per 100 thousand people, and the prevalence rate was 2.54 times higher and comprised 20.14 cases per 100 thousand people. The highest incidence indices were recorded in Kalush and Kolomyia districts that may be associated with developed chemical and oil-and-gas industry in this regions. Districts with highly developed wood-working industry are characterized by increased morbidity rate among males, who are actually engaged in this branch of national economy. The assessment of climatic factors made it possible to determine that the incidence rate was 1.65 times higher in the northern part of the region as compared to the southern districts. Conclusions: It has been established that geographic and ecological factors have a considerable influence on the incidence, prevalence and development of sarcoidosis.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122250560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. Rutkowska, I. Kwiecień, Aleksandra Szamałek, Joanna Zarzycka, K. Jahnz-Różyk, P. Rzepecki
{"title":"Immunophenotyping of CD34 + cells in peripheral blood of patients with lung sarcoidosis","authors":"E. Rutkowska, I. Kwiecień, Aleksandra Szamałek, Joanna Zarzycka, K. Jahnz-Różyk, P. Rzepecki","doi":"10.1183/13993003.congress-2019.pa1957","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1957","url":null,"abstract":"Sarcoidosis is a multisystemic granulomatous disease with still unknown etiology. Our previous studies showed a significantly higher percentage of CD34 + progenitor cells in the peripheral blood in patients with newly diagnosed sarcoidosis compared to the control group. The aim of the present study was to evaluate the immunophenotype of the CD34 + cell population in peripheral blood in patients with newly diagnosed sarcoidosis with reference to the control group. Peripheral blood was collected from 8 patients with newly diagnosed pulmonary sarcoidosis (with stages I or II of sarcoidosis) and 8 healthy subjects. The immunomagnetic method and flow cytometry with a panel of monoclonal antibodies were used for CD34 cells separation and identification. Among the CD34+ progenitor cells were assessed: low-differentiated cells CD45+dim CD133+ CD34+ HLA-DR+ CD38-, myeloid progenitor cells: CD45+dim CD34+ CD133+ CD38+/- HLA-DR+ CD117+ CD33-/+dim, lymphoid progenitor cells and endothelial cells. We observed a significantly higher percentage of low-differentiated cells (13.8 vs. 2.3, p In conclusion this study demonstrated for the first time the characterization of immunophenotype of peripheral CD34 + cells with the degree of their differentiation. The study confirmed the role of low-differentiated cells and endothelial cells in patients with sarcoidosis. This observation maybe important in the diagnosis, monitoring or prognosis of patients with sarcoidosis.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132450108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Schupp, T. Adams, B. Jäger, George Deluiis, F. Ahangari, N. Kaminski, A. Prasse
{"title":"Single Cell RNA Sequencing profiles Distinct BAL Cell Subpopulations in Sarcoidosis","authors":"J. Schupp, T. Adams, B. Jäger, George Deluiis, F. Ahangari, N. Kaminski, A. Prasse","doi":"10.1183/13993003.congress-2019.oa5154","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.oa5154","url":null,"abstract":"Background: Sarcoidosis is a systemic disease characterized histologically by nonnecrotizing granuloma, mainly affecting the lung and lymph nodes. Methods: BAL cells of sarcoidosis and IPF patients undergoing routine diagnostic work-up were obtained by bronchoscopy, healthy volunteers served as controls. Single cells were barcoded using the 10x Chromium Single Cell platform and cDNA libraries were prepared according to the manufacturer’s protocol. cDNA libraries were sequenced on an Illumina platform. Single cell gene expression of sarcoidosis and control lungs was compared using the Wilcoxon rank sum test. Results: So far, 160128 single BAL cell transcriptomes of 8 patients with sarcoidosis and 6 control lungs were established. Cells were clustered into major cell types, then immune cells consisting of 122220 alveolar macrophages, 4321 cytotoxic T-cells, and 6662 helper-T-cells (TH) were analyzed. We could identify unique gene expression profiles in BAL cells in sarcoidosis: TH-cells are characterized by increased expression of T-cell-receptor-subunits (TRAC, TRBC1, TRBC2), MHC class I molecules (HLA-A, HLA-B, HLA-C, and B2M), and inflammatory cytokines (IFNG, CCL4, LTB) compared to controls. Alveolar macrophages in sarcoidosis express genes associated with alternative activation like CCL18, FN1, VIM, smaller subpopulation however inflammatory cytokines like CXCL10. Macrophages show an increased MHC-class 1 gene expression, but also MHC-class-2 genes. Conclusions: Single cell transcriptomics identified the spectrum of distinct BAL cell subpopulations in sarcoidosis. Profiling of additional BAL cells and validation experiments are ongoing.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"196 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132538740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Quijano-Campos, M. Thillai, Marta Bravo-Teijeira, N. Sekhri, F. Kearl, H. Parfrey, E. Harris, K. Harding, R. Rowe, J. Sanders
{"title":"Treatment and management of cardiac sarcoidosis","authors":"J. Quijano-Campos, M. Thillai, Marta Bravo-Teijeira, N. Sekhri, F. Kearl, H. Parfrey, E. Harris, K. Harding, R. Rowe, J. Sanders","doi":"10.1183/13993003.congress-2019.pa1388","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1388","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115219715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H. Ohira, K. Yoshinaga, Shinya Sakiyama, Toshitaka Nakaya, Naoko Suzuki, Ayako Sugimoto, Akiko Hayashishita, O. Manabe, N. Oyama-Manabe, Taku Watanabe, I. Tsujino
{"title":"Prediction of corticosteroid responder in newly diagnosed cardiac sarcoidosis patients with complete heart block","authors":"H. Ohira, K. Yoshinaga, Shinya Sakiyama, Toshitaka Nakaya, Naoko Suzuki, Ayako Sugimoto, Akiko Hayashishita, O. Manabe, N. Oyama-Manabe, Taku Watanabe, I. Tsujino","doi":"10.1183/13993003.congress-2019.oa5159","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.oa5159","url":null,"abstract":"Background: Complete heart block (CHB) is a serious complication of cardiac sarcoidosis (CS) which requires pacemaker implantation. Some patients recover from CHB after steroid therapy. Aims and Objectives: To investigate whether cardiac imaging features including echocardiography (Echo), 18F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET), cardiac magnetic resonance imaging (CMR) or cardiac CT could predict recovery of CHB. Methods: Seventeen CS patients newly diagnosed with CHB who received steroid therapy were included. The presence of basal thinning of the interventricular septum (IVS) on Echo was evaluated. Focal myocardial FDG uptake on FDG-PET and delayed enhancement (DE) on CMR or CT were considered to be positive. The extent of the DE was classified into “none or mild fibrosis = less than one layer of the 3 myocardial layers” or “moderate or severe fibrosis = greater than 2 layers of the 3 myocardial layers”. Results: Six patients (35%) recovered from CHB and the remaining 11 patients (65%) did not. Six patients with recovery; no patients (0%) had basal thinning of the IVS (p = 0.02 vs without recovery), and 6 patients showed none or mild fibrosis of the basal IVS (p Conclusion: When Echo did not show basal thinning of the IVS and CMR or CT showed none or mild fibrosis of the basal IVS, the patients may recover from CHB.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127534423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Variants of the clinical course of familial pulmonary sarcoidosis","authors":"O. Baranova, M. M. Ilkovich, A. Speranskaya","doi":"10.1183/13993003.congress-2019.pa1395","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1395","url":null,"abstract":"The aim of the study was to identify variants of the clinical course of FPS. Methods: We found FPS in 26 patients from 1050 observed patients with pulmonary sarcoidosis (PS) for last 15 years. The group consisted of 12 families with 2 or more members suffering from PS. The mean age was 39±5,3 years. FPS was diagnosed after a clinical, radiological, functional and pathological evaluation in all 26 patients with FPS. Results: In all members of 6 families the course of PS was favorable - spontaneous regression in 4 cases and under the influence corticosteroid therapy in 2 cases. The course of PS in 3 families characterized frequent relapses with extrapulmonary lesions. In members of 3 families we found advanced pulmonary sarcoidosis (APS). APS was characterized by progressive dyspnea, significant fibrosing and fibrocystic pulmonary lesions at CT (HRCT) lung scans, and a restrictive impairment with reduced gas exchange on pulmonary function test results (varying degrees of severity). Patients of this families received systemic corticosteroids in combination with cytotoxic agents, 2 patients died within the 15 and 24 years of illness. The cause of death was respiratory failure. We observed cancer in 2 cases and lymphoma in one case in FPS patients (after diagnostics of sarcoidosis). Conclusion: Genetic predisposition plays a role in pulmonary sarcoidosis. FPS in half of cases had progressive and relapsing course and needs careful monitoring for evalution of dynamic of clinical symptoms, functional indicators, and radiological examination.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124624938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F. Jeny, V. Vučinić, D. Talwar, P. Bhattacharyya, I. Strâmbu, E. E. Lower, D. Valeyre, R. Baughman
{"title":"Validation of the Sarcoidosis Diagnostic Score in a multinational study","authors":"F. Jeny, V. Vučinić, D. Talwar, P. Bhattacharyya, I. Strâmbu, E. E. Lower, D. Valeyre, R. Baughman","doi":"10.1183/13993003.congress-2019.oa5155","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.oa5155","url":null,"abstract":"Introduction: The diagnosis of sarcoidosis is often delayed because of the reasons is the diverse presentation of sarcoidosis. Recently the Cincinnati team developed a Sarcoidosis Diagnostic Score(SDS) based on a modified WASOG organ assessment instrument (1). The aim of this study was to confirm the diagnostic value of SDS in a large multinational study, including patients with granulomatous lung diseases not due to sarcoidosis. Methods: This study was conducted in two sites in India (Kolkata, Noida), one in US (Cincinnati) and two in Europe (Belgrade, Greater Paris). There were 1341 cases including 567 with biopsy-confirmed sarcoidosis, 173 with other granulomatous disorders and 601 with non-granulomatous lung disorders. SDS biopsy and SDS clinical (without biopsy) scores were calculated. Positive cutpoint values were defined as ≥4 for clinical and ≥7 for SDS biopsy. Results: In the total sarcoidosis and non-sarcoid granulomatous populations, sensitivity and specificity for SDS biopsy were 100% and 28.9% and for SDS clinical 72.3% and 98.6%, respectively. Considering sarcoidosis and non-granulomatous disorders, Sensitivity and specificity in the sarcoid and non-granulomatous populations for SDS biopsy were 100% and 99.2% and for SDS clinical 73.2% and 91.7%, respectively. Conclusion: The SDS system provides a good discrimination between sarcoidosis and other non-granulomatous diseases similar to the previous report (1). For patients with non-sarcoidosis granulomatous disease, the SDS biopsy was not specific. However, patients with SDS clinical scores of ≥4 had a greater than 90% chance of being diagnosed with sarcoidosis. Higher scores were more likely to be sarcoidosis. Reference: 1) Bickett et al.Chest 2018,154(5)1052–60","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121604810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P. Cameli, L. Bergantini, F. Bianchi, M. Mazzei, P. Sestini, P. Rottoli, E. Bargagli
{"title":"Biomarkers of Sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme and KL-6","authors":"P. Cameli, L. Bergantini, F. Bianchi, M. Mazzei, P. Sestini, P. Rottoli, E. Bargagli","doi":"10.1183/13993003.congress-2019.pa1959","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1959","url":null,"abstract":"Background: Sarcoidosis is a systemic granulomatous disease with unknown etiology. Many clinical presentations have been reported and acute disease needs to be distinguished from subacute and chronic disease. The unpredictable clinical course of the disease prompted us to evaluate the clinical utility of biomarker serum detection in sarcoidosis follow-up. Objectives: To evaluate the potential role of many serum biomarkers in the clinical management of patients with Sarcoidosis. Methods: Serum concentrations of chitotriosidase, ACE, KL-6 and lysozyme were analyzed in a population of 74 patients with Sarcoidosis (46 on steroid therapy at sampling), regularly monitored at Siena Sarcoidosis Regional Referral Centre, and in a group of healthy controls. Clinical data, functional parameters and organ involvement were retrospectively collected in order to evaluate associations between specific features of disease and biomarkers’ overexpression. Results: KL-6 concentrations were significantly elevated in Sarcoidosis patients with lung fibrosis and were correlated with DLCO e Composite Physiological Index score, while chitotriosidase was significantly higher in patients with extrapulmonary localizations of disease. With a cut-off value of 303.5 IU/ml, KL-6 showed the best sensitivity (78%), while chitotriosidase reported the best specificity (85%) among the biomarkers. Conclusions: KL-6 is a reliable biomarker of fibrotic lung involvement, while chitotriosidase may be an indicator of extrapulmonary localizations of disease in Sarcoidosis patients. Among biomarkers, KL-6 and chitotriosidase showed the best sensitivity and the best specificity, respectively, even in patients on chronic steroid-therapy.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125664496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}